Moderna, Inc. (MRNA)
Moderna, Inc. Operating Income
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| Operating Income | ($223.8M) | ($269.4M) | ($413.3M) | ($545.7M) | ($763.1M) | $13.3B | $9,420.0M | ($4,239.0M) |
Moderna, Inc. (MRNA) Operating Income comparison analysis
MRNA key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Moderna, Inc.'s Operating Income?
As of today, Moderna, Inc.'s last 12-month Operating Income is ($2,693.0M), based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Moderna, Inc.'s Operating Income growth rate?
Over the last year, Moderna, Inc.'s Operating Income growth was 1.1%. The average annual Operating Income growth rates for Moderna, Inc. have been N/A over the past three years, 36.4% over the past five years.
3) Is Moderna, Inc.'s Operating Income growth rate Good?
Over the last year, Moderna, Inc.'s Operating Income growth was 1.1%, which is higher than industry growth of (0.1%). It indicates that Moderna, Inc.'s Operating Income growth is Good.